Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 4/20 | 0.41 |
| ▸ | CMKLR1 | Q99788 | 11/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL225588 | 0.88 | FFAR1 (0.51) | FFAR1 | |
| SCHEMBL2889482 | 0.87 | FFAR1 (0.45) | FFAR1CMKLR1MRGPRX4SLC22A12 | |
| SCHEMBL10077183 | 0.86 | FFAR1 (0.46) | FFAR1CMKLR1MRGPRX4SLC22A12 | |
| SCHEMBL2893994 | 0.79 | NR3C1 (0.42) | FFAR1ACACBMRGPRX4SLC22A12 | |
| SCHEMBL2885942 | 0.77 | NR3C1 (0.42) | FFAR1ACACBMRGPRX4SLC22A12 | |
| SCHEMBL224951 | 0.74 | FFAR1 (0.56) | FFAR1 | |
| SCHEMBL223927 | 0.73 | FFAR1 (0.57) | FFAR1 | |
| SCHEMBL225589 | 0.70 | FFAR1 (0.51) | FFAR1 | |
| SCHEMBL14567177 | 0.69 | FFAR1 (0.70) | FFAR1CMKLR1 | |
| SCHEMBL10077248 | 0.69 | FFAR1 (0.51) | FFAR1CMKLR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012010413-A1 | ARYLOXY-ALKYLENE SUBSTITUTED HYDROXYPHENYL HEXYNOIC ACIDS, METHODS FOR THE PRODUCTION THEREOF AND USE OF THE SAME AS MEDICAMENT | SANOFI (FR) | 2012-01-26 | — | — | WO | disclosed |
| US-20120004166-A1 | ARYLOXYALKYLENE-SUBSTITUTED HYDROXYPHENYLHEXYNOIC ACIDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT | SANOFI (FR) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004166-A1 | ARYLOXYALKYLENE-SUBSTITUTED HYDROXYPHENYLHEXYNOIC ACIDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT | HCAR1, HCAR3, CYP2C9 | FFAR1 83/4885CMKLR1 566/4885ACACB 2850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.